Recruiting
Phase 2

ABP-745

Sponsor:

Atom Therapeutics Co., Ltd

Code:

NCT07145229

Conditions

Acute Gouty Arthritis

Gout Flare

Gout Flares

Acute Gout Flare

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

ABP-745 Dose A

ABP-745 Dose B

Colchicine

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by Atom Therapeutics Co., Ltd on 2025-09-11.